Featured Stories
Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

Newly-Filed Plavix Lawsuits Claim Drug Caused Gastrointestinal Bleeds, Cerebral Hemorrhage, and TTP

The manufacturer of Plavix continues to be named in lawsuits alleging the blood thinner caused some patients to suffer from serious bleeding side effects. Most recently, the national law firm of Parker Waichman LLP filed nine Plavix bleeding lawsuits in state court in New York.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Smith & Nephew Recalls Metal-on-Metal Hip Implant Component

Medical device maker, Smith & Nephew, just issued a recall for a metal-on-metal hip implant component, a part of one of its all-metal hip replacement systems.

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

FDA Warning Letter Issued to Maker of ‘Craze’ Workout Supplement

Matt Cahill, who runs Driven Sports, has received a warning letter from the U.S. Food and Drug Administration (FDA) over concerns about the ingredients in Craze, a controversial workout supplement that is reported to have a methamphetamine-like compound. According to the letter, the agency questions whether several ingredients that are claimed to be from dendrobium orchids actually come from the plant. The FDA says that the proprietary blend of ingredients listed as “Dendrobex” made the product adulterated under federal law, since the agency was not aware of evidence that the ingredient was present in food supply. Additionally, the company never submitted any paperwork to have it permitted as a new dietary ingredient. Continue reading

Posted in Legal News |

At One in Three Nursing Homes Residents Are Abused, Study Says

One_in_Three_Residents_Abused_at_Nursing_HomesAt one in three nursing homes and long-term care facilities, residents suffer some form of abuse or neglect.

No state is exempt from abuse reports. According to a study by the Special Investigations Division of the House Government Reform Committee, 5,283 facilities in the U.S. were involved in almost 9,000 instances of abuse over a two-year period from January 1999 to January 2001, Carbonated.tv.com reports. The National Center on Elder Abuse (NCEA) of the Department of Health and Human Services estimates that only 1 in 14 cases of elder abuse ever comes to the attention of authorities.

Continue reading

Posted in Health Concerns, Nursing Home Abuse |

EMA also Investigates Link between Testosterone Drugs and Heart Problems

Testosterone_Drugs_and_Heart_ProblemsThe European Medicines Agency (EMA) is reviewing the cardiovascular risks of testosterone drugs, MedPage Today reports. Like the U.S. Food and Drug Administration (FDA) the agency is basing its investigation on two recent studies showing that the drugs are associated with a higher risk of heart attack and cardiovascular death. The review was prompted by the Estonian State Agency of Medicines and will be conducted by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC). Continue reading

Posted in Legal News |

Tenants In Building Near Harlem Explosion Site Sue for Toxic Exposure

Tenants-Near-Harlem-Explosion-SueTenants in a Harlem apartment building near the site of last month’s deadly gas explosion are suing their landlord and the city of New York for failing to test for allegedly unsafe levels of toxic substances, including lead and asbestos, inside their apartments.

The suit was filed on Friday in housing court by tenants of the12 apartments in the building at 89 East 116Street. The blast broke windows in their building, and dust and debris settled in the apartments. The explosion destroyed two buildings, 1146 and 1144 Park Avenue, Law360 reports. The Department of Housing Preservation and Development (HPD) initially issued a vacate order for 89 East 116, but rescinded it after finding no dangerous asbestos levels in the air around the building. Continue reading

Posted in Asbestos, Health Concerns, Legal News, Toxic Substances |

Remington Recalls Model 700 and Model Seven Rifles That Could Fire Unintentionally

remington_rifles_recalledThe Remington firearms company has initiated a voluntary safety recall of certain Model 700 and Model Seven rifles that can fire unintentionally, causing injury and possibly death.

The recalled rifles were manufactured between May 1, 2006 and April 9, 2014 and are equipped with X-Mark Pro, or XMP triggers. An “excess bonding agent being applied in the assembly process,” causes the problem, not the trigger itself, the recall notice says. Remington discovered that these rifles can fire unintentionally, creating a dangerous, possibly fatal, situation. The problem is specific to the XMP trigger only and other Model 700 and Model Seven rifles are unaffected by the recall, Guns.com reports. Rifles made after April 9, 2014 are not subject to recall. Continue reading

Posted in Defective Products, Product Recalls |

Abbott FreeStyle and FreeStyle Flash Blood Glucose Meters, Including those Built into OmniPod Personal Diabetes Manager Get Most Serious Recall Status

glucose_meters_recalledA class I recall was issued for Abbott Diabetes Care glucose meters FreeStyle and FressStyle Flash Blood Glucose Meters, including the FreeStyle Blood Glucose Meter built into the OmniPod Personal Diabetes Manage (PDM). The recall, which was initiated on February 19th, was issued due to an error that can cause the meters to falsely give a low blood sugar reading. The Class I recall is the most dangerous recall status, and the FDA states that “Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.” Continue reading

Posted in Legal News |

Two Covidien Brain Aneurysm Devices Recalled over Possibly Lethal Defect

Brain_Aneurysm_Device_Recal_Possible _Lethal _DefectDevice maker Covidien has recalled some of its Pipeline and Alligator brain embolism devices after discovering a potentially lethal problem with the devices’ guidewires.

Covidien identified a problem in the plastic coating on the device’s guidewire; the coating can delaminate and detach from the device, MassDevice.com reports. In a company press release Covidien explained, “Delamination of the PTFE coating could potentially lead to embolic occlusion [blockage] in the cerebral vasculature with the risk of stroke and/or death.” Covidien says that, to date, it has not received any reports of injuries related to the problem. The company has informed the U.S. Food and Drug Administration (FDA) and other regulatory agencies of the recall. Continue reading

Posted in Defective Medical Devices, Health Concerns, Product Recalls, Recalled Medical Devices |

European Medicines Agency Reviews Testosterone Drugs over Heart Risks

Testosterone-Therapy-Side-EffectsThe European Medicines Agency (EMA), the European Union’s drug regulators, has announced it will study the benefits and risks of testosterone replacement drugs in light of studies suggesting these drugs increase heart risks for the men who use them.

The agency will issue its opinion about whether authorization to market these medications should be maintained or should be changed, suspended or withdrawn across the group of 28 nations, Bloomberg News reports. Continue reading

Posted in Health Concerns, Pharmaceuticals |

2 Engineers Suspended in GM Ignition Switch Recall, Costs Rise to $1.5B

GM_Ignition_Switch_RecallA recent series of recalls, including a faulty ignition switch linked to 13 deaths, has led a number of problems for General Motors (GM) Co. Wall Street Journal reports that on Thursday, its estimated costs rose to $1.3 billion. GM’s original estimate was less than a third of the $1.3 billion charge, and this amount is also more than the company’s first quarter profit one year ago. Analysts expect the company will be posting its first quarterly net loss since it emerged from bankruptcy in 2009, WSJ reports. Additionally, the Detroit company has suspended two engineers involved in early decision-making.

GM has recalled 7 million vehicles worldwide since the start of the year. This includes a recall over a faulty ignition switch, which can cause cars to switch out of the “run” position, disabling the engine, air bags, steering, brakes and other safety measures. On Thursday, this recall was expanded to include lock cylinders that may allow keys to fall out while the car is running. GM said it was aware of one injury that occurred from an accident linked to when the key slipped out of the cylinder, causing a car to roll away. Continue reading

Posted in Legal News |

Questions About the Effectiveness of Tamiflu and Relenza Against Flu

Questions About the Effectiveness of Tamiflu and Relenza Against FluA new study questions the effectiveness of Tamiflu (oseltamivir) and Relenza (zanamivir) in preventing or reducing flu symptoms.

Health agency recommendations for the use of antivirals were based in part on findings from trials by drug manufacturers, including GlaxoSmithKline (GSK), Medical News Today (MNT) reports. Cochrane Review researchers hoped to verify the safety and effectiveness of neuraminidase inhibitors, but manufacturers refused to provide full access to clinical trial data, leading the researchers to question whether the risks and benefits of the antivirals have been accurately reported, and whether the drugs should be stockpiled for the treatment of seasonal and pandemic flu. The U.S. has spent over $1.3 billion on reserves of influenza antivirals. Continue reading

Posted in Health Concerns, Pharmaceuticals |